Loading the security overview…
Where the tokens are
Nine pass-or-fail tests of profitability, balance-sheet strength and efficiency, against the year before.
Figures describe Merck shares, not any token. From the company's filings, scored by each published model. 7 of 7 models had a result. Each model is one statistical lens on the filings and was built for a particular kind of company; none of them is a verdict, and none is advice.
A weighted sum of five balance-sheet ratios that has historically separated companies heading for bankruptcy from the rest.
Uses the modified formula. The original was fitted to manufacturers, and a company with a very large market value against small liabilities can score far off the usual scale.
Eight ratios that tend to move when reported earnings are being flattered. Above −1.78 the model flags the company.
A model of the probability of default within two years, from size, leverage, liquidity and profitability.
Eight tests built for growth companies, each comparing the company with the median of its industry.
Compared with 682 companies in the same industry group (SIC 28).
Greenblatt's ranking: cheap on earnings yield and good on return on capital, each ranked across the universe and the ranks added.
A rank, not a grade: lower is better, and it moves with the price as well as the business.
How much of reported profit arrived as cash. The Sloan ratio is the accrued, non-cash share of earnings against assets.